View in EDS

A CCHFV DNA vaccine protects against heterologous challenge and establishes GP38 as immunorelevant in mice.

Saved in:

Bibliographic Details
Title:	A CCHFV DNA vaccine protects against heterologous challenge and establishes GP38 as immunorelevant in mice.
Authors:	Suschak JJ; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA. jjsuschak@gmail.com., Golden JW; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA., Fitzpatrick CJ; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA., Shoemaker CJ; Diagnostics Systems Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA., Badger CV; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA., Schmaljohn CS; Headquarters Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA.; National Institute of Allergy and Infectious Diseases, Integrated Research Facility, Frederick, MD, USA., Garrison AR; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA. aura.r.garrison.civ@mail.mil.
Source:	NPJ vaccines [NPJ Vaccines] 2021 Mar 02; Vol. 6 (1), pp. 31. Date of Electronic Publication: 2021 Mar 02.
Publication Type:	Journal Article
Journal Info:	Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2059-0105
DOI:	10.1038/s41541-021-00293-9